Nasorhinathiol (Oxymetazoline Hydrochloride)

Oxymetazoline is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it stimulates α1‑ and α2‑receptors on vascular smooth muscle, causing vasoconstriction. This reduces blood flow and edema in the nasal passages, leading to rapid decongestion.

The specific dosing regimen for Nasorhinathiol is determined by the prescribing healthcare professional. In general, OTC nasal sprays are used as directed on the product label, typically one or two sprays per nostril, not exceeding the recommended maximum daily frequency.

Safety data for oxymetazoline in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Nasorhinathiol.

To place an order, submit an enquiry on the Nasorhinathiol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other OTC decongestants such as phenylephrine, oxymetazoline generally provides a longer duration of action (up to 12 hours) and a more rapid onset of relief. However, all topical decongestants share the risk of rebound congestion if used beyond the recommended short‑term period.

Store Nasorhinathiol at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nasorhinathiol is a nasal spray. Before use, gently blow the nose to clear passages. Insert the nozzle into one nostril, close the opposite nostril, and spray the recommended number of sprays. Repeat in the other nostril if directed, and avoid blowing the nose immediately after administration.

Serious but rare risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant elevation of blood pressure or heart rate, severe allergic reactions such as rash, swelling or difficulty breathing, and nasal ulceration or persistent nosebleeds. Seek medical attention if any of these occur.

Nasorhinathiol should be avoided by individuals with known hypersensitivity to oxymetazoline or any excipients, patients taking monoamine oxidase inhibitors, children under six years of age unless specifically prescribed, and anyone with uncontrolled hypertension or severe cardiovascular disease without prior medical advice.